Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.59 USD | +6.00% | +4.79% | +0.44% |
05-10 | Edesa Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
03-05 | Top Premarket Gainers | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
14.76M | - | - | - | - | - | |
121B | ||||||
107B | ||||||
24.82B | - | |||||
22.48B | - | |||||
18.32B |
- Stock Market
- Equities
- EDSA Stock
- Charts Edesa Biotech, Inc.
- Sector Chart